Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
11.125
GBX
2.3%
Market Closed
Market Cap:
£45.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
O
|
Oesterreichische Post AG
VSE:POST
|
AT |
|
A
|
Arrowroot Acquisition Corp
NASDAQ:AILE
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Creo Medical Group PLC (CREO)
under the Base Case is
1.811
GBX.
Compared with the current market price of 11.125 GBX, the stock appears
Overvalued by 84%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CREO
Multiples-Based Value
Base Case
1.811
GBX
Overvaluation 84%
Multiples Across Competitors
CREO Competitors Multiples
Creo Medical Group PLC Competitors
Creo Medical Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Creo Medical Group PLC
LSE:CREO
|
45.9m GBP | 20.9 | 2.7 | -3.1 | -2.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.8B USD | 4.1 | 27.5 | 15.8 | 21.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16.3 | 57.5 | 43.6 | 53.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127B USD | 5.2 | 39.9 | 20.4 | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.9B USD | 3.2 | 24.6 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.7B USD | 4.6 | 31.9 | 18.9 | 25.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.7B EUR | 1.8 | 20.2 | 11.3 | 15.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 10.9 | 44.3 | 31.4 | 34.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.2 | 22.6 | 15.9 | 17.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
